Author:
Alsabhan Jawza F.,Almalag Haya M.,Aljafali Lubna,Alnughamish Hessa,Almutlaq Gaida
Subject
Pharmaceutical Science,Pharmacology
Reference20 articles.
1. Assessment of potential drug interactions among psychiatric inpatients receiving antipsychotic therapy of a secondary care hospital, United Arab Emirates;Aburamadan;J. Adv. Pharm. Technol. Res.,2021
2. Alkhadhari, S., al Zain, N., Darwish, T., Khan, S., Okasha, T., Ramy, H., & Tadros, T. M. (2015). Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the middle east. Neuropsychiatric Disease and Treatment, 11. https://doi.org/10.2147/NDT.S78788.
3. Patterns of psychiatric diagnoses in inpatient and outpatient psychiatric settings in Saudi Arabia;Alosaimi;Rev. Psiquiatria Clin.,2017
4. Antipsychotic polypharmacy is associated with adverse drug events in psychiatric inpatients: The Japan adverse drug events study;Ayani;J. Clin. Psychopharmacol.,2021
5. Englisch, S., & Zink, M. (2012). Treatment-resistant schizophrenia: Evidence-based strategies. In Mens Sana Monographs (Vol. 10, Issue 1, pp. 20–32). https://doi.org/10.4103/0973-1229.91588.